share_log

OncoSec Medical Incorporated (NASDAQ:ONCS) Short Interest Down 60.2% in December

OncoSec Medical Incorporated (NASDAQ:ONCS) Short Interest Down 60.2% in December

OncoSec Medical Incorporated（纳斯达克股票代码：ONCS）12月空头利率下降60.2％
Financial News Live ·  2023/01/18 17:51

OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) saw a large decline in short interest in December. As of December 30th, there was short interest totalling 45,700 shares, a decline of 60.2% from the December 15th total of 114,700 shares. Currently, 3.2% of the shares of the company are short sold. Based on an average daily volume of 897,800 shares, the days-to-cover ratio is presently 0.1 days.

OncoSec Medical Incorporated（纳斯达克股票代码：ONCS — 获取评级）在12月份的空头利率大幅下降。截至12月30日，空头利率共计45,700股，较12月15日的114,700股下降了60.2％。目前，该公司有3.2％的股票被卖空。根据897,800股的平均每日成交量，目前的天数与覆盖率为0.1天。

OncoSec Medical Trading Down 13.4 %

OncoSec Medical 交易下跌13.4％

Shares of NASDAQ:ONCS traded down $0.34 during trading on Wednesday, hitting $2.19. 267,558 shares of the stock were exchanged, compared to its average volume of 348,514. The company has a fifty day moving average price of $4.55 and a two-hundred day moving average price of $10.26. The company has a market cap of $6.50 million, a PE ratio of -0.13 and a beta of 1.59. OncoSec Medical has a 12-month low of $1.50 and a 12-month high of $31.90.

纳斯达克股票代码：ONCS的股价在周三的交易中下跌了0.34美元，至2.19美元。该股交易了267,558股，而平均交易量为348,514股。该公司的五十天移动平均价格为4.55美元，两百天移动平均线价格为10.26美元。该公司的市值为650万美元，市盈率为-0.13，beta值为1.59。OncoSec Medical创下12个月低点1.50美元，12个月高点为31.90美元。

Get
获取
OncoSec Medical
OncoSec医疗
alerts:
警报：

Analyst Upgrades and Downgrades

分析师升级和降级

Several equities research analysts have recently commented on ONCS shares. StockNews.com started coverage on OncoSec Medical in a research note on Sunday, January 8th. They set a "sell" rating on the stock. BTIG Research lowered OncoSec Medical from a "buy" rating to a "neutral" rating in a research note on Monday, November 14th.

几位股票研究分析师最近对ONCS股票发表了评论。StockNews.com在1月8日星期日的一份研究报告中开始报道OncoSec Medical。他们对该股设定了 “卖出” 评级。BTIG Research在11月14日星期一的一份研究报告中将OncoSec Medical的评级从 “买入” 下调至 “中性”。

Institutional Inflows and Outflows

机构流入和流出

An institutional investor recently raised its position in OncoSec Medical stock. Bank of New York Mellon Corp increased its stake in shares of OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) by 653.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 386,074 shares of the biotechnology company's stock after purchasing an additional 334,849 shares during the period. Bank of New York Mellon Corp owned 0.98% of OncoSec Medical worth $444,000 as of its most recent SEC filing.
一位机构投资者最近提高了其在OncoSec Medical股票中的头寸。根据纽约银行向美国证券交易委员会（SEC）提交的最新13F文件，纽约银行梅隆公司在第一季度将其在OncoSec Medical Incorporated（纳斯达克股票代码：ONCS — Get Rating）的股份增加了653.7％。该基金在此期间又购买了334,849股股票后，拥有这家生物技术公司的386,074股股票。截至美国证券交易委员会最近提交的文件，纽约银行梅隆公司拥有OncoSec Medical0.98％的股份，价值44.4万美元。

OncoSec Medical Company Profile

OncoSec Medical 公司简介

(Get Rating)

（获取评分）

OncoSec Medical, Inc is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor.

OncoSec Medical, Inc是一家生物技术公司，专注于设计、开发和商业化疗法和专有医学方法，以刺激和指导治疗癌症的抗肿瘤免疫反应。其主要候选产品ImmunoPulse IL-12 使用电穿孔设备，目的是逆转治疗肿瘤中的免疫抑制微环境。

See Also

另见

  • Get a free copy of the StockNews.com research report on OncoSec Medical (ONCS)
  • What does Nu Holdings Stock Have To Do With Warren Buffett?
  • J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
  • Is Intel Stock On The Verge Of Breaking Out?
  • Does it Matter Folks Aren't "Starry-Eyed" Over Pepsi's New Soda?
  • Can Alaska Air Continue Soaring Above The Airline Industry?
  • 免费获取 StockNews.com 关于 OncoSec Medical (ONCS) 的研究报告的副本
  • Nu Holdings 的股票与沃伦·巴菲特有什么关系？
  • J.B. Hunt 持平，物流公司成为人们关注的焦点
  • 英特尔股票即将爆发吗？
  • 人们不对百事可乐的新苏打水 “满眼相看” 有关系吗？
  • 阿拉斯加航空能否继续飞越航空业？

Receive News & Ratings for OncoSec Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OncoSec Medical and related companies with MarketBeat.com's FREE daily email newsletter.

接收 OncoSec《医学日报》的新闻和评级 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收OncoSec Medical及相关公司的最新新闻和分析师评级的简明每日摘要。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发